Jefferies Group’s Regenxbio RGNX Stock Holding History

Jefferies Group’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-8,166	Closed	-$419K	–	2976
2019 Q2	$419K	Buy	8,166 +4,029	+97%	+$201K	﹤0.01%	1757
2019 Q1	$237K	Sell	4,137 -5,525	-57%	-$274K	﹤0.01%	1884
2018 Q4	$405K	Buy	+9,662	New	+$567K	﹤0.01%	1544

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jefferies Group's RGNX Position: Q3 2019 in Review

Jefferies Group sold out of Regenxbio (RGNX) in Q3 2019, closing a stake of 8,166 shares — an estimated $419K sold.

Jefferies Group first reported a position in RGNX in Q4 2018 and held it in 3 quarters. The position peaked at $419K in Q2 2019. 168 funds tracked by Wall St. Rank hold RGNX as of Q3 2019.

Jefferies Group reported no remaining Regenxbio position as of Q3 2019 after selling out during the quarter.
Jefferies Group sold 8,166 Regenxbio shares in Q3 2019, an estimated $419K.
Jefferies Group first reported a position in Regenxbio in Q4 2018 and held it in 3 quarters.
Jefferies Group's Regenxbio position peaked at $419K in Q2 2019.
168 funds tracked by Wall St. Rank held Regenxbio as of Q3 2019.

Based on Jefferies Group's 13F filing for Q3 2019, filed 13 Nov 2019.